DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Arava (Leflunomide) - Summary

 

-- advertisement --

CONTRAINDICATIONS AND WARNINGS

PREGNANCY MUST BE EXCLUDED BEFORE THE START OF TREATMENT WITH ARAVA. ARAVA IS CONTRAINDICATED IN PREGNANT WOMEN, OR WOMEN OF CHILDBEARING POTENTIAL WHO ARE NOT USING RELIABLE CONTRACEPTION. (SEE CONTRAINDICATIONS AND WARNINGS.) PREGNANCY MUST BE AVOIDED DURING ARAVA TREATMENT OR PRIOR TO THE COMPLETION OF THE DRUG ELIMINATION PROCEDURE AFTER ARAVA TREATMENT.

 

ARAVA SUMMARY

ARAVA® Tablets
(leflunomide)
10 mg, 20 mg, 100 mg

ARAVA® (leflunomide) is a pyrimidine synthesis inhibitor. The chemical name for leflunomide is N-(4'-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide.

ARAVA is indicated in adults for the treatment of active rheumatoid arthritis (RA):

  1. to reduce signs and symptoms
  2. to inhibit structural damage as evidenced by X-ray erosions and joint space narrowing
  3. to improve physical function.

(see CLINICAL STUDIES)

Aspirin, nonsteroidal anti-inflammatory agents and/or low dose corticosteroids may be continued during treatment with ARAVA (see PRECAUTIONS -- Drug Interactions -- NSAIDs). The combined use of ARAVA with antimalarials, intramuscular or oral gold, D penicillamine, azathioprine, or methotrexate has not been adequately studied (see WARNINGS -- Immunosuppression Potential/Bone Marrow Suppression).

ARAVA NEWS HIGHLIGHTS

Media Articles Related to Arava (Leflunomide)

Study Examines How Rheumatoid Arthritis Destroys Bone
Source: MedicineNet Arthritis Specialty [2008.08.25]

Discovery Of How Rheumatoid Arthritis Causes Bone Loss Holds Implications For Autoimmune Disease And Osteoporosis
Source: Arthritis / Rheumatology News From Medical News Today [2008.08.22]

Study Examines How Rheumatoid Arthritis Destroys Bone (HealthDay)
Source: Y! Health Arthritis News [2008.08.22]

Pipex Pharmaceuticals Acquires Late-Stage Oral Phase II Candidate For Rheumatoid Arthritis
Source: Arthritis / Rheumatology News From Medical News Today [2008.08.21]

Scientists To Develop Rheumatoid Arthritis Vaccine
Source: Arthritis / Rheumatology News From Medical News Today [2008.08.15]

more>>

Published Studies Related to Arava (Leflunomide)

Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. [2007.07]

Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. [2007.05.22]

Safety and efficacy of Leflunomide in primary Sjogren's syndrome - A phase II pilot study. [2007.01.12]

Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy. [2006.04]

Combination of cyclosporine and leflunomide versus single therapy in severe rheumatoid arthritis. [2006.03]

more>>

Clinical Trials Related to Arava (Leflunomide)

Triple III Comparison of Leflunomide Alone Versus Two DMARD Combinations in the Treatment of Rheumatoid Arthritis [Active, not recruiting]

Bioavailability Study of Leflunomide Tablets Under Fed Conditions [Completed]

Bioavailability Study of Leflunomide Tablets Under Fasting Conditions [Completed]

Leflunomide + Methotrexate in Rheumatoid Arthritis [Completed]

Leflunomide to Treat Uveitis [Completed]

more>>

Page last updated: 2008-08-25

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008